Ovarian Cancer Case 01
INITIAL PET/CT FINDINGS: There was a focal abnormal area of increased radiopharmaceutical uptake that was not visible on the CT portion of the exam.
FOLLOW-UP PET/CT FINDINGS: One year later the patient returned for a PET/CT scan and now has wide-spread disease throughout the abdomen.
One year later, after her CA-125 levels continued to rise, the patient returned for a follow-up PET/CT scan, which demonstrated wide-spread abdominal disease.
The power of combined PET/CT imaging is in localizing disease before an abnormality is apparent on CT images. Physicians gain added confidence in their decision to treat a patient that has a negative CT scan, but has rising CA-125 levels and abnormal increased radiopharmaceutical uptake on the combined PET/CT scan.
Data courtesy of Dr. Todd Blodgett, University of Pittsburgh Medical Center, Pittsburgh, PA, USA
* Any of the protocols presented herein are for informational purposes and are not meant to substitute for clinician judgment in how best to use any medical devices. It is the clinician that makes all diagnostic determinations based upon education, learning and experience.